Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes

[1] Agmo A(1998)The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide Neuropharmacology 37 223-232

[2] Belzung C(1995)Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review Psychopharmacology 120 186-194

[3] Agmo A(1999)Blockade of anxiolytic-like actions of chlordiazepoxide by naloxone in the elevated plus-maze: comparisons between Swiss, C57BL/6 and BALB/c mice Psychobiology 27 105-113

[4] Galvan A(2001)Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes Behav Neurosci 115 443-454

[5] Heredia A(2005)Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol 19 567-596

[6] Morales M(2005)Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice Psychopharmacology 181 260-269

[7] Agmo A(1975)Opiate receptor binding in mice: genetic differences Life Sci 17 633-638

[8] Belzung C(1997)Naloxone blocks anxiolytic-like effects of benzodiazepines in Swiss but not BALB/c mice Psychopharmacology 132 195-201

[9] Deloire X(1997)Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice Eur J Pharmacol 323 133-136

[10] Grassin M(2000)Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat Eur J Pharmacol 394 289-294

[1] Agmo A(1998)The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide Neuropharmacology 37 223-232

[2] Belzung C(1995)Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review Psychopharmacology 120 186-194

[3] Agmo A(1999)Blockade of anxiolytic-like actions of chlordiazepoxide by naloxone in the elevated plus-maze: comparisons between Swiss, C57BL/6 and BALB/c mice Psychobiology 27 105-113

[4] Galvan A(2001)Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes Behav Neurosci 115 443-454

[5] Heredia A(2005)Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol 19 567-596

[6] Morales M(2005)Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice Psychopharmacology 181 260-269

[7] Agmo A(1975)Opiate receptor binding in mice: genetic differences Life Sci 17 633-638

[8] Belzung C(1997)Naloxone blocks anxiolytic-like effects of benzodiazepines in Swiss but not BALB/c mice Psychopharmacology 132 195-201

[9] Deloire X(1997)Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice Eur J Pharmacol 323 133-136

[10] Grassin M(2000)Naloxone potentiates anxiolytic-like actions of diazepam, pentobarbital and meprobamate but not those of Ro19-8022 in the rat Eur J Pharmacol 394 289-294